Early prediction of response in interferon monotherapy and in interferon-ribavirin combination therapy for chronic hepatitis C: HCV RNA at 4 weeks versus ALT-Reference-Cited by-同舟云学术

Early prediction of response in interferon monotherapy and in interferon-ribavirin combination therapy for chronic hepatitis C: HCV RNA at 4 weeks versus ALT

Published:1999-02 Issue:2 Volume:30 Page:192-198
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Brouwer Johannes T.,Hansen Bettina E.,Niesters Hubert G.M.,Schalm Solko W.

Publisher

Elsevier BV

Subject

Hepatology

Reference22 articles.

1. National Institutes of Health Consensus Development Conference Panel Statement: management of hepatitis C.;Anonymous;Hepatology,1997

2. A French consensus conference on hepatitis C: screening and treatment;Dhumeaux;J Hepatol,1997

3. Randomized trial comparing three different regimens of alpha-2a-interferon in chronic hepatitis C. The TriVeneto Viral Hepatitis Group;Chemello;Hepatology,1995

4. Interferon alfa-2b for chronic hepatitis C: effects of dose increment and duration of treatment on response rates. Results of the first multicentre Australian trial. Australia Hepatitis C Study Group;Lin;J Hepatol,1995

5. A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group;Poynard;N Engl J Med,1995

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interleukin-10 promoter polymorphisms in hepatitis C patients with and withoutSchistosoma mansonico-infection;Liver International;2009-10

2. Correlates and Prognostic Value of the First‐Phase Hepatitis C Virus RNA Kinetics during Treatment;Clinical Infectious Diseases;2009-08-15

3. IL-10 promoter gene polymorphisms and sustained response to combination therapy in Taiwanese chronic hepatitis C patients;Digestive and Liver Disease;2009-06

4. Management of Hepatitis C virus Genotype 2 or 3 Infection: Treatment Optimization on the Basis of Virological Response;Antiviral Therapy;2009-02

5. The genetic differences with whole genome linkage disequilibrium mapping between responder and non-responder in interferon-α and ribavirin combined therapy for chronic hepatitis C patients;International Journal of Immunogenetics;2008-04